Dihydrotanshinone I as a novel signal transducer and activator of transcription 3 inhibitor for glioblastoma treatment.
Saved in:
| Title: | Dihydrotanshinone I as a novel signal transducer and activator of transcription 3 inhibitor for glioblastoma treatment. |
|---|---|
| Authors: | Cheng KW; Department of Medical Research Center, Shaoxing People's Hospital, School of Medicine, ShaoXing University, Shaoxing, 312000, China.; Department of Neurology, Shaoxing People's Hospital, Shaoxing, 312000, China., Zhou SJ; Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou, 310058, China., Zeng J; Department of Neurology, Shaoxing People's Hospital, Shaoxing, 312000, China.; School of Medicine, ShaoXing University, Shaoxing, 312000, China., Zhang YR; Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou, 310058, China., Jin BQ; School of Medicine, ShaoXing University, Shaoxing, 312000, China., Wang P; Department of Blood Transfusion, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing, 312000, China., He LY; Department of Traditional Chinese Medicine, Shaoxing People's Hospital, Zhejiang University Shaoxing Hospital, Shaoxing, China., Qi XC; Department of Neurosurgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310024, China., Liu XD; Bioengineering College of Chongqing University, Chongqing, 400030, China. liuxubio@126.com., Yu LS; Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. yuls@zju.edu.cn.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou, 310058, China. yuls@zju.edu.cn., Zhang YX; Department of Neurology, Shaoxing People's Hospital, Shaoxing, 312000, China. auwxf01@163.com.; School of Medicine, ShaoXing University, Shaoxing, 312000, China. auwxf01@163.com.; State Key Laboratory of Neurology and Oncology Drug Development, Jiangsu Simcere Pharmaceutical Co. Ltd., 699-18 Xuan Wi Avemue, Nanjing, Jiangsu, 210042, China. auwxf01@163.com. |
| Source: | Journal of translational medicine [J Transl Med] 2026 Jun 11. Date of Electronic Publication: 2026 Jun 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42277880 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Dihydrotanshinone I as a novel signal transducer and activator of transcription 3 inhibitor for glioblastoma treatment. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Cheng+KW%22">Cheng KW</searchLink>; Department of Medical Research Center, Shaoxing People's Hospital, School of Medicine, ShaoXing University, Shaoxing, 312000, China.; Department of Neurology, Shaoxing People's Hospital, Shaoxing, 312000, China.<br /><searchLink fieldCode="AU" term="%22Zhou+SJ%22">Zhou SJ</searchLink>; Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou, 310058, China.<br /><searchLink fieldCode="AU" term="%22Zeng+J%22">Zeng J</searchLink>; Department of Neurology, Shaoxing People's Hospital, Shaoxing, 312000, China.; School of Medicine, ShaoXing University, Shaoxing, 312000, China.<br /><searchLink fieldCode="AU" term="%22Zhang+YR%22">Zhang YR</searchLink>; Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou, 310058, China.<br /><searchLink fieldCode="AU" term="%22Jin+BQ%22">Jin BQ</searchLink>; School of Medicine, ShaoXing University, Shaoxing, 312000, China.<br /><searchLink fieldCode="AU" term="%22Wang+P%22">Wang P</searchLink>; Department of Blood Transfusion, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing, 312000, China.<br /><searchLink fieldCode="AU" term="%22He+LY%22">He LY</searchLink>; Department of Traditional Chinese Medicine, Shaoxing People's Hospital, Zhejiang University Shaoxing Hospital, Shaoxing, China.<br /><searchLink fieldCode="AU" term="%22Qi+XC%22">Qi XC</searchLink>; Department of Neurosurgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310024, China.<br /><searchLink fieldCode="AU" term="%22Liu+XD%22">Liu XD</searchLink>; Bioengineering College of Chongqing University, Chongqing, 400030, China. liuxubio@126.com.<br /><searchLink fieldCode="AU" term="%22Yu+LS%22">Yu LS</searchLink>; Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. yuls@zju.edu.cn.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou, 310058, China. yuls@zju.edu.cn.<br /><searchLink fieldCode="AU" term="%22Zhang+YX%22">Zhang YX</searchLink>; Department of Neurology, Shaoxing People's Hospital, Shaoxing, 312000, China. auwxf01@163.com.; School of Medicine, ShaoXing University, Shaoxing, 312000, China. auwxf01@163.com.; State Key Laboratory of Neurology and Oncology Drug Development, Jiangsu Simcere Pharmaceutical Co. Ltd., 699-18 Xuan Wi Avemue, Nanjing, Jiangsu, 210042, China. auwxf01@163.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101190741%22">Journal of translational medicine</searchLink> [J Transl Med] 2026 Jun 11. <i>Date of Electronic Publication: </i>2026 Jun 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101190741 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1479-5876 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214795876%22">14795876 </searchLink><i>NLM ISO Abbreviation: </i>J Transl Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42277880 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12967-026-08385-7 Languages: – Code: eng Text: English Titles: – TitleFull: Dihydrotanshinone I as a novel signal transducer and activator of transcription 3 inhibitor for glioblastoma treatment. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cheng KW – PersonEntity: Name: NameFull: Zhou SJ – PersonEntity: Name: NameFull: Zeng J – PersonEntity: Name: NameFull: Zhang YR – PersonEntity: Name: NameFull: Jin BQ – PersonEntity: Name: NameFull: Wang P – PersonEntity: Name: NameFull: He LY – PersonEntity: Name: NameFull: Qi XC – PersonEntity: Name: NameFull: Liu XD – PersonEntity: Name: NameFull: Yu LS – PersonEntity: Name: NameFull: Zhang YX IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 06 Text: 2026 Jun 11 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1479-5876 Titles: – TitleFull: Journal of translational medicine Type: main |
| ResultId | 1 |